Small-molecule ligands bind to a distinct pocket in Ras and inhibit SOS-mediated nucleotide exchange activity

Till Maurer, Lindsay S. Garrenton, Angela Oh, Keith Pitts(Toxicologie, Pharmacologie et Signalisation Cellulaire), Daniel J. Anderson, Nicholas J. Skelton, Benjamin P. Fauber, Borlan Pan, Shiva Malek(Toxicologie, Pharmacologie et Signalisation Cellulaire), David Stokoe, Mary J. C. Ludlam, Krista K. Bowman, Jiansheng Wu, Anthony M. Giannetti(Toxicologie, Pharmacologie et Signalisation Cellulaire), Melissa A. Starovasnik, Ira Mellman, Peter K. Jackson, Joachim Rudolph, Weiru Wang, Guowei Fang
Proceedings of the National Academy of Sciences
March 19, 2012
Cited by 629Open Access
Full Text

Abstract

The Ras gene is frequently mutated in cancer, and mutant Ras drives tumorigenesis. Although Ras is a central oncogene, small molecules that bind to Ras in a well-defined manner and exert inhibitory effects have not been uncovered to date. Through an NMR-based fragment screen, we identified a group of small molecules that all bind to a common site on Ras. High-resolution cocrystal structures delineated a unique ligand-binding pocket on the Ras protein that is adjacent to the switch I/II regions and can be expanded upon compound binding. Structure analysis predicts that compound-binding interferes with the Ras/SOS interactions. Indeed, selected compounds inhibit SOS-mediated nucleotide exchange and prevent Ras activation by blocking the formation of intermediates of the exchange reaction. The discovery of a small-molecule binding pocket on Ras with functional significance provides a new direction in the search of therapeutically effective inhibitors of the Ras oncoprotein.


Related Papers

No related papers found

Powered by citation graph analysis